Jesus, J.A.; Fragoso da Silva, T.N.; Yamamoto, E.S.; G. Lago, J.H.; Dalastra Laurenti, M.; Passero, L.F.D.
Ursolic Acid Potentializes Conventional Therapy in Experimental Leishmaniasis. Pathogens 2020, 9, 855.
https://doi.org/10.3390/pathogens9100855
AMA Style
Jesus JA, Fragoso da Silva TN, Yamamoto ES, G. Lago JH, Dalastra Laurenti M, Passero LFD.
Ursolic Acid Potentializes Conventional Therapy in Experimental Leishmaniasis. Pathogens. 2020; 9(10):855.
https://doi.org/10.3390/pathogens9100855
Chicago/Turabian Style
Jesus, Jéssica Adriana, Thays Nicolli Fragoso da Silva, Eduardo Seiji Yamamoto, João Henrique G. Lago, Márcia Dalastra Laurenti, and Luiz Felipe Domingues Passero.
2020. "Ursolic Acid Potentializes Conventional Therapy in Experimental Leishmaniasis" Pathogens 9, no. 10: 855.
https://doi.org/10.3390/pathogens9100855
APA Style
Jesus, J. A., Fragoso da Silva, T. N., Yamamoto, E. S., G. Lago, J. H., Dalastra Laurenti, M., & Passero, L. F. D.
(2020). Ursolic Acid Potentializes Conventional Therapy in Experimental Leishmaniasis. Pathogens, 9(10), 855.
https://doi.org/10.3390/pathogens9100855